EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA

Objective: To investigate the effects of intravitreal triamcinolone for refractory diabetic maculopathy after 03 unsuccessful intravitreal bevacizumab injections. Study Design: Prospective observational study. Place and Duration of Study: Retina department of Al-Shifa Trust Eye Hospital Rawalp...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ume Sughra, Anwar Ahmed Gul, Kashif Habib, Zeeshan Khan, Ozeer Khan
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2021
Materias:	central macular thickness diabetic macular edema diabetic retinopathy diabetes intravitreal bevacizumab Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/31e9ec55a5b44f1dafb201baa8958828
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:31e9ec55a5b44f1dafb201baa8958828
record_format	dspace
spelling	oai:doaj.org-article:31e9ec55a5b44f1dafb201baa89588282021-11-24T05:55:45ZEFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA0030-96482411-8842https://doaj.org/article/31e9ec55a5b44f1dafb201baa89588282021-10-01T00:00:00Zhttps://www.pafmj.org/index.php/PAFMJ/article/view/5305/3638https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To investigate the effects of intravitreal triamcinolone for refractory diabetic maculopathy after 03 unsuccessful intravitreal bevacizumab injections. Study Design: Prospective observational study. Place and Duration of Study: Retina department of Al-Shifa Trust Eye Hospital Rawalpindi, from Jun 2016 to Jul 2017. Methodology: Total 35 eyes of 35 patients who were diagnosed with diabetic maculopathy and having history of minimum three intravitreal Bevacizumab injections were included. Detailed eye examinations included visual acuity, anterior and posterior segment examination and intraocular pressure measurement was performed in all patients. Central macular thickness was also measured. Then intravitreal triamcinolone was administered to eyes by principal researcher (Ophthalmologist). After one month, follow up examination of patient’s eyes was done to assess the effects of injection. Results: Majority of the participants were males 19 (55%) in this research. There was statistically significant difference between means of intra ocular pressure (mean difference= 4.30 ± 5.41), Visual acuity (mean difference=2.8 ± 2.4) and central macular thickness (mean difference = 236.4 ± 13) pre and post injection was found (p-value<0.05). Conclusion: There was statistically significant difference of central macular thickness and visual acuity, pre and post intravitreal triamcinolone acetonide injection was found.Ume SughraAnwar Ahmed GulKashif HabibZeeshan KhanOzeer KhanArmy Medical College Rawalpindiarticlecentral macular thicknessdiabetic macular edemadiabetic retinopathydiabetesintravitreal bevacizumabMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 71, Iss 5, Pp 1861-1864 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	central macular thickness diabetic macular edema diabetic retinopathy diabetes intravitreal bevacizumab Medicine R Medicine (General) R5-920
spellingShingle	central macular thickness diabetic macular edema diabetic retinopathy diabetes intravitreal bevacizumab Medicine R Medicine (General) R5-920 Ume Sughra Anwar Ahmed Gul Kashif Habib Zeeshan Khan Ozeer Khan EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
description	Objective: To investigate the effects of intravitreal triamcinolone for refractory diabetic maculopathy after 03 unsuccessful intravitreal bevacizumab injections. Study Design: Prospective observational study. Place and Duration of Study: Retina department of Al-Shifa Trust Eye Hospital Rawalpindi, from Jun 2016 to Jul 2017. Methodology: Total 35 eyes of 35 patients who were diagnosed with diabetic maculopathy and having history of minimum three intravitreal Bevacizumab injections were included. Detailed eye examinations included visual acuity, anterior and posterior segment examination and intraocular pressure measurement was performed in all patients. Central macular thickness was also measured. Then intravitreal triamcinolone was administered to eyes by principal researcher (Ophthalmologist). After one month, follow up examination of patient’s eyes was done to assess the effects of injection. Results: Majority of the participants were males 19 (55%) in this research. There was statistically significant difference between means of intra ocular pressure (mean difference= 4.30 ± 5.41), Visual acuity (mean difference=2.8 ± 2.4) and central macular thickness (mean difference = 236.4 ± 13) pre and post injection was found (p-value<0.05). Conclusion: There was statistically significant difference of central macular thickness and visual acuity, pre and post intravitreal triamcinolone acetonide injection was found.
format	article
author	Ume Sughra Anwar Ahmed Gul Kashif Habib Zeeshan Khan Ozeer Khan
author_facet	Ume Sughra Anwar Ahmed Gul Kashif Habib Zeeshan Khan Ozeer Khan
author_sort	Ume Sughra
title	EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
title_short	EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
title_full	EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
title_fullStr	EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
title_full_unstemmed	EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
title_sort	effect of intravitreal triamcinolone acetonide in refractory diabetic macular edema
publisher	Army Medical College Rawalpindi
publishDate	2021
url	https://doaj.org/article/31e9ec55a5b44f1dafb201baa8958828
work_keys_str_mv	AT umesughra effectofintravitrealtriamcinoloneacetonideinrefractorydiabeticmacularedema AT anwarahmedgul effectofintravitrealtriamcinoloneacetonideinrefractorydiabeticmacularedema AT kashifhabib effectofintravitrealtriamcinoloneacetonideinrefractorydiabeticmacularedema AT zeeshankhan effectofintravitrealtriamcinoloneacetonideinrefractorydiabeticmacularedema AT ozeerkhan effectofintravitrealtriamcinoloneacetonideinrefractorydiabeticmacularedema
_version_	1718415905589821440

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA

Ejemplares similares